Use of Serum Antiopoietin-2 Assay for Therapeutic Decision-Making in Patients with Vascular Anomalies
Elissa Engel(Cincinnati Children's Hospital Medical Center), Lori Luchtman‐Jones(Cincinnati Children's Hospital Medical Center), Karen Mittermeier(Cincinnati Children's Hospital Medical Center), Kiersten Ricci(Cincinnati Children's Hospital Medical Center), Timothy LeCras(Cincinnati Children's Hospital Medical Center), Adrienne M. Hammill(Cincinnati Children's Hospital Medical Center)
Cited by 1
Related Papers
Efficacy of systemic sirolimus in the treatment of generalized lymphatic anomaly and Gorham–Stout disease
|Pediatric Blood & Cancer|2019|126
Vascular Anomalies
|Hematology/Oncology Clinics of North America|2019|122
Knowledge insufficient: the management of haemoglobin SC disease
|British Journal of Haematology|2016|63
How we approach the diagnosis and management of complex lymphatic anomalies
|Pediatric Blood & Cancer|2021|52
Advances in the Medical Management of Vascular Anomalies
|Seminars in Interventional Radiology|2017|47